Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.
Maury P, Baratto F, Zeppenfeld K, Klein G, Delacretaz E, Sacher F, Pruvot E, Brigadeau F, Rollin A, Andronache M, Maccabelli G, Gawrysiak M, Brenner R, Forclaz A, Schlaepfer J, Lacroix D, Duparc A, Mondoly P, Bouisset F, Delay M, Hocini M, Derval N, Sadoul N, Magnin-Poull I, Klug D, Haïssaguerre M, Jaïs P, Della Bella P, De Chillou C. Maury P, et al. Among authors: klug d. Eur Heart J. 2014 Jun 7;35(22):1479-85. doi: 10.1093/eurheartj/ehu040. Epub 2014 Feb 16. Eur Heart J. 2014. PMID: 24536081
Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR, Abraham WT, Weaver FA, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, Müller-Ehmsen J, Schafer JE, Senni M, Swarup V, Wachter R, Little WC. Zile MR, et al. Among authors: klug d. Eur J Heart Fail. 2015 Oct;17(10):1066-74. doi: 10.1002/ejhf.299. Epub 2015 Jun 10. Eur J Heart Fail. 2015. PMID: 26011593 Free article. Clinical Trial.
Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study.
Clementy N, Challal F, Marijon E, Boveda S, Defaye P, Leclercq C, Deharo JC, Sadoul N, Klug D, Piot O, Gras D, Bordachar P, Algalarrondo V, Fauchier L, Babuty D; DAI-PP Investigators. Clementy N, et al. Among authors: klug d. Heart Rhythm. 2017 Feb;14(2):211-217. doi: 10.1016/j.hrthm.2016.10.024. Epub 2016 Oct 28. Heart Rhythm. 2017. PMID: 27989789
Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
Weaver FA, Abraham WT, Little WC, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, Madershahian N, Müller-Ehmsen J, Schafer JE, Senni M, Swarup V, Wachter R, Zile MR. Weaver FA, et al. Among authors: klug d. Semin Thorac Cardiovasc Surg. 2016 Summer;28(2):320-328. doi: 10.1053/j.semtcvs.2016.04.017. Epub 2016 Jun 2. Semin Thorac Cardiovasc Surg. 2016. PMID: 28043438 Free article. Clinical Trial.
Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
Halbach M, Abraham WT, Butter C, Ducharme A, Klug D, Little WC, Reuter H, Schafer JE, Senni M, Swarup V, Wachter R, Weaver FA, Wilks SJ, Zile MR, Müller-Ehmsen J. Halbach M, et al. Among authors: klug d. Int J Cardiol. 2018 Sep 1;266:187-192. doi: 10.1016/j.ijcard.2018.04.075. Epub 2018 Apr 21. Int J Cardiol. 2018. PMID: 29705650 Clinical Trial.
Cardiac resynchronisation therapy reduces functional mitral regurgitation during dynamic exercise in patients with chronic heart failure: an acute echocardiographic study.
Ennezat PV, Gal B, Kouakam C, Marquie C, LeTourneau T, Klug D, Lacroix D, Logeart D, Cohen-Solal A, Dennetière S, Van Belle E, Deklunder G, Asseman P, de Groote P, Kacet S, LeJemtel TH. Ennezat PV, et al. Among authors: klug d. Heart. 2006 Aug;92(8):1091-5. doi: 10.1136/hrt.2005.071654. Epub 2005 Dec 30. Heart. 2006. PMID: 16387811 Free PMC article.
Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator.
Boudghène-Stambouli F, Boulé S, Goéminne C, Botcherby E, Marquié C, Kouakam C, Guédon-Moreau L, Schurtz G, de Groote P, Lamblin N, Fertin M, Robin E, Brigadeau F, Klug D, Lacroix D, Meurice J, Wissocque L, Vincentelli A, Kacet S. Boudghène-Stambouli F, et al. Among authors: klug d. J Interv Card Electrophysiol. 2014 Mar;39(2):177-84. doi: 10.1007/s10840-013-9854-y. Epub 2013 Dec 13. J Interv Card Electrophysiol. 2014. PMID: 24338204 Clinical Trial.
Safety, feasibility, and outcome results of cardiac resynchronization with triple-site ventricular stimulation compared to conventional cardiac resynchronization.
Anselme F, Bordachar P, Pasquié JL, Klug D, Leclercq C, Milhem A, Alonso C, Deharo JC, Gras D, Probst V, Piot O, Savouré A. Anselme F, et al. Among authors: klug d. Heart Rhythm. 2016 Jan;13(1):183-9. doi: 10.1016/j.hrthm.2015.08.036. Epub 2015 Sep 26. Heart Rhythm. 2016. PMID: 26325531 Free article. Clinical Trial.
Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry.
Providência R, Marijon E, Lambiase PD, Bouzeman A, Defaye P, Klug D, Amet D, Perier MC, Gras D, Algalarrondo V, Deharo JC, Leclercq C, Fauchier L, Babuty D, Bordachar P, Sadoul N, Piot O, Boveda S. Providência R, et al. Among authors: klug d. J Am Heart Assoc. 2016 Feb 12;5(2):e002756. doi: 10.1161/JAHA.115.002756. J Am Heart Assoc. 2016. PMID: 26873687 Free PMC article.
374 results